IOBT

IOBT

IO Biotech Inc. Common Stock

$1.500+0.000 (0.000%)

Precio en Tiempo Real

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.500

Máximo

$1.500

Mínimo

$1.500

Volumen

0.38M

Fundamentos de la Empresa

Estadísticas de Negociación

Noticias Relacionadas

GlobeNewswire

IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that

Ver más
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
GlobeNewswire

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025Data presented at recent

Ver más
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights